Aspen Aerogels (NYSE:ASPN) Stock Price Down 4.9% After Analyst Downgrade

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) was down 4.9% during mid-day trading on Friday after Roth Mkm lowered their price target on the stock from $22.00 to $16.00. Roth Mkm currently has a buy rating on the stock. Aspen Aerogels traded as low as $8.54 and last traded at $8.56. Approximately 1,276,875 shares changed hands during trading, a decline of 35% from the average daily volume of 1,978,913 shares. The stock had previously closed at $9.00.

Other equities research analysts have also recently issued research reports about the company. StockNews.com raised Aspen Aerogels to a "sell" rating in a research note on Saturday, February 8th. Craig Hallum lowered their price target on Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating for the company in a report on Friday. Seaport Res Ptn lowered shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research note on Friday. Finally, Barclays dropped their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $24.67.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in ASPN. Lord Abbett & CO. LLC purchased a new position in Aspen Aerogels in the 3rd quarter valued at approximately $10,126,000. Oppenheimer & Co. Inc. raised its stake in shares of Aspen Aerogels by 167.2% in the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock valued at $2,839,000 after acquiring an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC boosted its holdings in Aspen Aerogels by 337.5% in the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock valued at $436,000 after purchasing an additional 27,000 shares during the period. Penserra Capital Management LLC acquired a new position in Aspen Aerogels during the 3rd quarter worth $1,342,000. Finally, Geode Capital Management LLC grew its stake in Aspen Aerogels by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Trading Down 1.0 %

The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $701.12 million, a PE ratio of 855.36 and a beta of 2.14. The company has a fifty day simple moving average of $12.06 and a two-hundred day simple moving average of $18.36.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Analysts anticipate that Aspen Aerogels, Inc. will post 0.12 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.